Dorsey & Whitney Trust CO LLC Has $851,000 Position in CME Group Inc. (NASDAQ:CME)

Dorsey & Whitney Trust CO LLC grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 5.8% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,327 shares of the financial services provider’s stock after acquiring an additional 237 shares during the period. Dorsey & Whitney Trust CO LLC’s holdings in CME Group were worth $851,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of CME. B. Riley Wealth Advisors Inc. lifted its stake in CME Group by 1.3% in the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after acquiring an additional 48 shares during the last quarter. Capital Advisors Ltd. LLC boosted its holdings in CME Group by 4.3% in the first quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after purchasing an additional 48 shares in the last quarter. Lantz Financial LLC increased its position in CME Group by 1.1% during the first quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock worth $982,000 after buying an additional 49 shares during the last quarter. Lester Murray Antman dba SimplyRich raised its holdings in CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after buying an additional 50 shares in the last quarter. Finally, Greystone Financial Group LLC lifted its position in shares of CME Group by 1.6% in the fourth quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock worth $691,000 after buying an additional 52 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on CME shares. Deutsche Bank Aktiengesellschaft increased their price objective on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a report on Thursday, August 15th. Piper Sandler reiterated an “overweight” rating and set a $225.00 price target on shares of CME Group in a report on Tuesday, August 20th. Bank of America cut shares of CME Group from a “neutral” rating to an “underperform” rating and reduced their price objective for the stock from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Keefe, Bruyette & Woods raised their target price on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. Finally, Barclays boosted their target price on shares of CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 25th. Four analysts have rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $209.73.

Insider Activity

In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other CME Group news, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the transaction, the director now directly owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. The disclosure for this sale can be found here. Corporate insiders own 0.30% of the company’s stock.

CME Group Stock Down 0.0 %

NASDAQ CME opened at $218.48 on Wednesday. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $223.80. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $78.67 billion, a PE ratio of 24.86, a PEG ratio of 8.92 and a beta of 0.55. The firm has a 50-day simple moving average of $204.40 and a 200 day simple moving average of $207.55.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping the consensus estimate of $2.53 by $0.03. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. CME Group’s revenue for the quarter was up 12.7% compared to the same quarter last year. During the same quarter last year, the firm earned $2.30 EPS. On average, research analysts forecast that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be paid a $1.15 dividend. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date is Monday, September 9th. CME Group’s dividend payout ratio is 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.